Ceramics have low toughness as determined by testing under a tensile load; often, ceramics have 
  
    
      
        
          
            K
          
          
            
              c
            
          
        
      
    
    {\textstyle \mathrm {K} _{\mathrm {c} }}
   values that are ~5% of that found in metals. However, ceramics are usually loaded in compression in everyday use, so the compressive strength is often referred to as the strength; this strength can often exceed that of most metals. However, ceramics are brittle and thus most work done revolves around preventing brittle fracture. Due to how ceramics are manufactured and processed, there are often preexisting defects in the material introduce a high degree of variability in the Mode I brittle fracture. Thus, there is a probabilistic nature to be accounted for in the design of ceramics.
The benefit of tafasitamab was evaluated by measuring how many participants had a complete or partial tumor shrinkage and how long that response lasted (called best overall response rate). Society and culture
Names
Tafasitamab is the international nonproprietary name (INN). References
External links
"Tafasitamab". Drug Information Portal. U.S. National Library of Medicine. Clinical trial number NCT02399085 for "A Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL (L-MIND)" at ClinicalTrials.gov